Home▸Articles▸Biomarker Discovery Proteomics

SOMAscan Aptamer-Based Proteomics Panel: A Revolution in Biomarker Discovery

A cutting-edge technology that enables the simultaneous analysis of thousands of proteins for biomarker discovery and disease diagnosis.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is the SOMAscan Aptamer-Based Proteomics Panel?

The SOMAscan platform utilizes a unique class of molecules called SOMAmer aptamers to detect and quantify thousands of proteins simultaneously. These aptamers are synthetic oligonucleotides that can be designed to bind specifically to target proteins, making them highly versatile for various biological applications.

By leveraging the high specificity and sensitivity of these aptamers, the SOMAscan panel allows researchers to analyze a wide range of protein biomarkers in a single assay, significantly reducing the time and cost associated with traditional proteomics methods.

How Does It Work?

The process begins by immobilizing the SOMAmer aptamers on a microarray. When a sample containing proteins is introduced, these aptamers selectively bind to their target proteins. The bound complexes are then detected using fluorescently labeled probes that specifically recognize the aptamer-protein interactions.

This method allows for high-throughput analysis of thousands of protein targets in parallel, providing comprehensive insights into complex biological systems and disease states.

live demo · related simulation● LIVE

Why Is It Important?

The SOMAscan panel is crucial for identifying novel biomarkers that can be used to diagnose diseases at an early stage. By detecting changes in protein expression levels, researchers can gain a deeper understanding of disease mechanisms and develop more effective therapeutic strategies.

Moreover, the ability to analyze multiple proteins simultaneously enhances the reliability and robustness of proteomics studies, making it a valuable tool in both basic research and clinical diagnostics.

Real-World Applications

The SOMAscan platform has been applied in various fields, including cancer research, where it helps identify biomarkers for early detection of tumors. It is also used in cardiovascular disease studies to monitor protein levels that indicate risk factors and progression.

Additionally, the technology is employed in drug development to assess the efficacy of new treatments by monitoring changes in relevant protein targets.

Frequently asked questions

What are aptamers?

Aptamers are short single-stranded DNA or RNA molecules that can bind specifically and tightly to target proteins, similar to antibodies but with the advantage of being more stable and easier to produce.

How does SOMAscan compare to traditional proteomics methods?

SOMAscan offers higher throughput and broader coverage compared to traditional methods like mass spectrometry. It can analyze thousands of proteins in a single assay, whereas conventional techniques typically focus on one or a few proteins at a time.

Can SOMAscan detect post-translational modifications?

SOMAscan primarily detects the presence of target proteins but does not directly measure post-translational modifications. However, it can be used in conjunction with other techniques to study these modifications.

Is the SOMAscan panel suitable for all types of samples?

The SOMAscan platform is generally applicable to a wide range of sample types, including blood, tissue extracts, and cell culture supernatants. However, optimal conditions may vary depending on the specific protein targets and sample matrix.

Try it live

Everything above runs in your browser — open SOMAscan Aptamer-Based Proteomics Panel and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open SOMAscan Aptamer-Based Proteomics Panel simulation

What did you find?

Add reproduction steps (optional)